Aime et al., 1992, “Synthesis, Characterization and 1/T1 NMRD Profiles of Gadolinium (III) Complexes of Monoamide Derivatives of DOTA-like Ligands. X-ray Structure of the 10-[-2-[2-Hydroxy-1-(hydroxymethyl)ethyl]-1-[(phenylmethoxy)methyl]-2-oxo-ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-triacetic Acid-Gadolinium(III) Complex”, Inorg. Chem., 31:2422-2428. |
Aime et al., 2000, “Multinuclear and multifrequency NMR study of gadolinium(III) complexes with bis-amide derivatives of ethylenedioxydiethylene-dinitrilotetraacetic acid”, J. Chem. Soc., Dalton Trans. 2000(19):3435-3440. |
Amedio et al., 1999, “A Practical Manufacturing Synthesis of 1-(R)-Hydroxymethyl-DPTA: An Important Intermediate in the Synthesis of MRI Contrast Agents”, Synthetic Communications, 29(14):2377-2391. |
Amedio et al., 2000, “Preparation of N,N-BIS2-[N',N'-BIS[(Tert-Butoxycarbonyl)Methyl]-Amino]Ethyl-L-Aspartic Acid: An Intermediate in the Synthesis of MRI Contrast Agents”, Synthetic Communications, 30(20):3755-3763. |
Augustijns et al., 1995, “Peptidyl Dipeptidase A-Catalyzed Metabolism of Delta Sleep-Inducing Peptide in Bovine Brain Microvessel Endothelial Cells: A Cell Culture Model of the Blood Brain Barrier”, Biochem. and Biophysical Research Comm., 210:987-994. |
Bard et al., 1993, “BisMSH-DTPA: A Potential Imaging Agent for Malignant Melanoma”, Ann NY Acad Sci, 680:451-453. |
Bligh et al., 1994, “Neutral Gadolinium(III) Complexes of Bulky Octadentate dtpa Derivatives as Potential Contrast Agents for Magnetic Resonance Imaging”, Polyhedron 14:567-569. |
Brasch, Robert C., 1991, “Rationale and Applications for Macromolecular Gd-Based Contrast Agents”, Magnetic Resonance in Medicine, 22:282-287. |
Caravan et al., 1999, “Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics and Applications”, Chem. Rev. 99:2293-2352. |
Deacon et al., 1995, “Degradation of Glucagon-Like Peptide-1 by Human Plasma in Vitro Yields an N-Terminally Truncated Peptide that is a Major Endogenous Metabolite in Vivo”, Journal of Clinical Endocrinology and Metabolism, 80:952-957. |
Kolc, J., 1969, Amino Acids and Peptides. LXXXIX. Synthesis of L-4-Azalysine, D-4-Azalysine, and L-4-Azalysine-[6-14C], Collection Czechoslov. Chem. Commun., 34:630-634. |
Konings et al., 1990, “Gadolinium Complexation by a New DPTA-Amide Ligand. Amide Oxygen Coordination”, Inorg. Chem. 29:1488-1491. |
Krieter et al., 1989, “In Vivo Metabolism of Atrial Natriuretic Peptide: Identification of Plasma Metabolites and Enzymes Responsible for Their Generation”, The Journal of Pharmacology and Experimental Therapeutics, 249:411-417. |
Lauffer, R. B., 1987, “Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design”, Chem. Rev. 87:901-927. |
Liu et al., 1999, “Tc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals”, Chem. Rev. 99:2235-2268. |
Moats et al., 1997, “A ‘Smart ’ Magnetic Resonance Imaging Agent That Reports on Specific Enzymatic Activity”, Angew. Chem. Int. Ed. Engl. 36:726-728. |
Muller et al., 1995, “Metabolism of Dynorphin A 1-13 in Human Blood and Plasma”, Pharmaceutical Research, 12:1165-1170. |
Muller et al., 1999, “Assessment of Complex Peptide Degradation Pathways via Structured Multicompartmental Modeling Approaches: The Metabolism of Dynorphin A1-13 and Related Fragments in Human Plasma”, Journal of Pharmaceutical Sciences, 88:938-944. |
Muller et al., 1999, “Physicochemical Characterization of MS-325, a New Gadolinium Complex, by Multinuclear Reaxaxometry”, Eur. J. Inorg. Chem., 1999:1949-1955. |
Muller et al., 1996, “Interspecies comparison of in vitro plasma degradation of dynorphin A 1-13”, Pharmazie 51:581-585. |
Murphey et al., 2000, “Metabolism of Bradykinin In Vivo in Humans: Identification of BK1-5 as a Stable Plasma Peptide Metabolite”, Journal of Pharmacology and Experimental Therapeutics, 29(1)4:263-269. |
Peltier et al., 1993, “Radioimmunodetection of Medullary Thyroid Cancer Using a Bispecific Anti-CEA/Anti-Indium-DTPA Antibody and an Indium-111-Labeled DTPA Dimer”, J. Nuc. Med., 34:1267-1273. |
Powell et al., 1996, “Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach”, J. Am. Chem. Soc., 118:9333-9346. |
Powell et al., 1993, “Peptide Stability in Drug Development. II. Effect of Single Amino Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum”, Pharmaceutical Research, 10(9):1268-1273. |
Powell, M.F., 1993, “Peptide Stability in Drug Development: In Vitro Peptide Degradation in Plasma and Serum”, Annual Reports in Medicinal Chemistry, 28:285-294. |
Ranganathan et al., 1998, “New Multimeric Magnetic Resonance Imaging Agents”, Investigative Radiology, 33(11):779-797. |
Swanson et al., 1993, “Laminin Peptide Fragments for Malignant Tumor Detection”, J. Nucl. Med. 34(5 suppl.)231P. |
Toth et al., 1997, “Tuning water-exchange rates on (carboxymethyl)iminobis-ethyleneitrilo)tetraacetate (dtpa)-type gadolinium (III) complexes”, J. Chem. Soc., Dalton Trans. 1997(9):1587-1594. |
Villringer et al., 1988, “Dynamic Imaging with Lanthanide Chelates in Normal Brain: Contrast Due to Magnetic Susceptibility Effects”, Magnetic Resonance in Medicine, 6:164-174. |
Wettergren et al., 1998, “Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans”, Regulatory Peptides, 77:83-87. |
Zhao et al., 1999, “Oxidation of Primary Alcohols to Carboxylic Acids with Sodium Chlorite Catalyzed by TEMPO and Bleach”, J. Org. Chem. 64:2564-2566. |
Clackson et al., 1998, “Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity”, Proc. Natl. Acad. Sci. USA, 95:10437-10442. |
Huber et al., 1998, “Fluorescently Detectable Magnetic Resonance Imaging Agents”, Bioconjugate Chem., 9:242-249. |
Kramer, R. H. and Karpen, J. W., 1998, “Spanning binding sites on allosteric proteins with polymer-linked ligand dimers”, Nature, 395:710-713. |
Lee et al., 1992, “Multivalent Ligand Binding by Serum Mannose-Binding Protein”, Arch. Biochem. Biophys., 299:129-136. |
Mann et al., 1998, “Probing Low Affinity and Multivalent Interactions with Surface Plasmon Resonance: Ligands for Concanavalin A”, J. Am. Chem. Soc., 120:10575-10582. |
Rao et al., 1998, “A Trivalent System from Vancomycin•D-Ala-D-Ala with Higher Affinity Than Avidin•Biotin”, Science, 280:708-711. |
Shukla et al., 1997, “Alteration Of Electronic Relaxation In MR Contrast Agetns Through De-Novo Ligand Design”, Acta Radiologica, 38 Suppl. 412:121-123. |
Shukla et al., 1996, “Design of Conformationally Rigid Dimeric MRI Agents”, Mag. Reson. Med., 35:928-931. |
Spevak et al., 1996, “Carbohydrates in an Acidic Multivalent Assembly: Nanomolar P-Selectin Inhibitors”, J. Med. Chem., 39:1018-1020. |